Texas Biomedical Research Institute is a 501(c)(3) organization based in San Antonio, Texas, registered in 1953, with $75,183,345 in FY2024 revenue. CharityIndex grades it C+, and it directs about 55% of spending to programs.
Revenue (FY2024)
$75.2M
▼ 9.7% vs prior year
Medical Research median: $217K
Expenses (FY2024)
$94.6M
Net assets
$141.9M
Employees
549
Measures how much of every dollar spent actually reaches programs, plus what it costs to raise $100 of donations. The worse of the two measures sets the letter (85%+ to programs is an A; under $15 to raise $100 is an A), averaged over the three most recent filings. For Texas Biomedical Research Institute: 55% to programs · $1 to raise $100 earns a C on this criterion. See the exact thresholds →
Measures whether the organization is built to last: how many months its reserves would cover expenses (3+ months earns an A-range score, but hoarding 5+ years of budget is capped) and whether it runs a surplus or a deficit. For Texas Biomedical Research Institute: 18 mo reserves · -26% margin earns a D on this criterion. See the exact thresholds →
Checks how the organization is run, from its own Form 990: an independent board majority, a board of five or more, conflict-of-interest, whistleblower and document-retention policies, and independently audited financials. The share of disclosed checks that pass sets the letter. For Texas Biomedical Research Institute: 6 of 6 checks met earns a A+ on this criterion. See the exact thresholds →
Counts five disclosure signals: a recent filing, a mission statement, program descriptions, a listed website, and the full expense breakdown. More disclosure, better letter. For Texas Biomedical Research Institute: 5 of 5 disclosure signals earns a A+ on this criterion. See the exact thresholds →
Show this grade on your website
A live seal — it updates automatically when the grade changes and links donors to this verified profile.
Texas biomed is pioneering and sharing scientific breakthroughs that protect you, your families and our global community from the threat of infectious diseases.
Texas biomed performs research on infectious diseases and associated chronic conditions that increase susceptibility to infection. these include basic research of host and pathogen biology, genetics, immunology and physiology.
Revenue grew from $55.8M (FY2013) to $75.2M (FY2024) across 12 reported years.
Financial snapshot
Operating margin
-25.9%
Spent more than it raised in the latest fiscal year.
Total assets
$366.6M
Total liabilities
$224.7M
Net assets
$141.9M
Salaries & benefits
$48.1M
51% of expenses
Board members
31
30 independent
| Fiscal year | Revenue | Expenses | Net assets | Total assets | Form |
|---|---|---|---|---|---|
| 2024 | $75,183,345▼9.7% | $94,648,073▲13.0% | $141,893,365▼6.0% | $366,564,882▲48.6% | 990 |
| 2023 | $83,244,840▲28.0% | $83,762,418▲15.5% | $151,029,442▲9.9% | $246,678,578▲5.2% | 990 |
| 2022 | $65,045,950▼10.8% | $72,503,664▲1.1% | $137,456,287▼12.9% | $234,572,359▼8.6% | 990 |
| 2021 | $72,880,870▲12.2% | $71,727,339▲11.4% | $157,895,934▲6.0% | $256,689,852▲14.1% | 990 |
| 2020 | $64,983,284▲9.9% | $64,404,841▼0.3% | $148,985,406▲5.6% | $224,998,467▲6.2% | 990 |
| 2019 | $59,102,578▲21.8% | $64,582,051▼2.3% | $141,058,432▲6.7% | $211,857,703▲12.9% | 990 |
| 2018 | $48,509,326▲8.3% | $66,103,978▲4.8% | $132,195,516▼16.2% | $187,657,988▼6.6% | 990 |
| 2017 | $44,798,603▼0.6% | $63,049,565▲8.4% | $157,709,656▼1.7% | $200,838,020▲5.3% | 990 |
| 2016 | $45,065,462▼12.6% | $58,163,938▲1.7% | $160,382,776▼4.4% | $190,745,333▼2.9% | 990 |
| 2015 | $51,568,963▼14.1% | $57,207,092▼6.1% | $167,796,786▼5.4% | $196,369,232▼7.3% | 990 |
| 2014 | $60,012,193▲7.6% | $60,914,264▲7.1% | $177,341,760▲0.8% | $211,837,738▲2.7% | 990 |
| 2013 | $55,751,717 | $56,857,340▲1.8% | $175,951,184▲7.0% | $206,318,204▼6.6% | 990 |
| 2012 | — | $55,862,868▼4.1% | $164,461,358▲8.1% | $221,013,864▲11.4% | 990 |
| 2011 | — | $58,274,714 | $152,094,194 | $198,416,357 | 990 |
Original Form 990 PDFs (the Form column) are served by ProPublica Nonprofit Explorer, as filed with the IRS. Create a free account to download the CSV report.
Highest-paid: Dr Larry Schlesinger — $794,181 (0.84% of total expenses)
| Name | Title | Hours/week | Compensation |
|---|---|---|---|
| Dr Larry Schlesinger | President, Ceo | 40 | $794,181 |
| Mr Bruce Edwards | Executive Vp, Cfo | 40 | $465,009 |
| Dr Cory Hallam | Executive Vp, Asi | 40 | $341,482 |
| Dr Deepak Kaushal | Professor (research) | 40 | $335,813 |
| Mrs Corinna Ross | Director, Snprc | 40 | $291,873 |
| Mrs Rebecca Madere | Vp, Human Resources | 40 | $288,988 |
| Mr John Marty Heaner Jr | Vp, It and Cto | 40 | $286,062 |
| Dr Jordi Torrelles | Professor (research) | 40 | $277,278 |
| Dr Timothy Anderson | Professor (research) | 40 | $270,440 |
| Mr Matt Majors | Vp, Operations | 40 | $265,861 |
| Dr Edward Dick Jr | Professor (veterinarian) | 40 | $262,492 |
| Dr Ricardo Carrion Jr | Professor (asi) | 40 | $260,407 |
| Mrs Shelley Cole | Interim Vp, Research | 40 | $241,841 |
| Mr David Q Bates Jr | Trustee | 1 | $98,346 |
| Dr C Collins Andy Anderson III | Trustee | 1 | — |
| Dr Craig Frances | Trustee | 1 | — |
| Dr Dacia Napier | Trustee | 1 | — |
| Dr George Peoples Jr | Trustee | 1 | — |
| Dr James Jamo Rubin | Vice Chairman | 1 | — |
| Dr Mitchell Kronenberg | Trustee | 1 | — |
| Contractor | Services | Paid |
|---|---|---|
| Alterman Inc | Electrical Construction | $5,163,226 |
| Spawglass Contractors Inc | Construction | $3,854,430 |
| Fisher Scientific | Lab Supplies | $2,568,705 |
| Joeris General Contractors LLC | Construction | $1,787,961 |
| Flad & Associates Inc | Architect | $1,323,947 |
133 grants to Texas Biomedical Research Institute totaling $22.0M, reported by foundations on their Schedule I filings — showing the 15 most recent.
| Grantmaker | Purpose | Year | Amount |
|---|---|---|---|
| American Lung Association | Research | 2024 | $400,000 |
| American Cancer Society Inc | Patient support | 2024 | $122,975 |
| International Aids Vaccine Initiative Inc | Research & development | 2024 | $61,388 |
| Ayco Charitable Foundation | Medical / public services | 2024 | $10,000 |
| San Antonio Area Foundation | General support | 2024 | $8,400 |
| International Aids Vaccine Initiative Inc | Research & development | 2023 | $1,667,115 |
| Scripps Research Institute | Grants for scientific research | 2023 | $724,962 |
| New York Medical College | Research | 2023 | $402,135 |
| Fidelity Investments Charitable Gift Fund | For grant recipient's exempt purposes | 2023 | $263,550 |
| Johns Hopkins University | Sub-award | 2023 | $239,025 |
| Emory University | Research/subcontract | 2023 | $178,344 |
| Trustees of Columbia University | Research | 2023 | $125,757 |
| Mayo Clinic Group Return | Support charitable programs | 2023 | $116,607 |
| University of Chicago | Subaward | 2023 | $96,046 |
| President and Fellows of Harvard College | Sponsored research sub-award | 2023 | $51,895 |
Explore more
Data for Texas Biomedical Research Institute (EIN 74-1109630) comes from the IRS Business Master File and e-filed Form 990 returns, via CharityIndex. Figures reflect what the organization reported to the IRS for each fiscal year.